INVO's logo.
Ticker Symbol: INVO

INVO Bioscience Inc

$3.24 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001417926

Company Profile

INVO Bioscience is a medical device company focused on creating simplified, lower cost treatments for patients diagnosed with infertility. Our solution, the INVO Procedure, is a disruptive new technology. The INVO Procedure is a revolutionary in vivo method of vaginal incubation that offers patients a more natural and intimate experience. Our lead product, the INVOcell, is a patented medical device used in infertility treatment and is considered an Assisted Reproductive Technology (ART). The INVOcell is the first Intravaginal Culture (IVC) system in the world used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development, as an alternative to traditional In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI). Our mission is to increase access to care and expand fertility treatment across the globe with a goal to lower the cost of care and increase availability of care.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: N/A
CEO: N/A
Tags:
  • Miscellaneous
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

Pricing

Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $0.68
Change: $0.05 ( 8.16%)
Days Range: $0.63 - $0.71
Beta: 0.65
52wk. High: $25.40
52wk. Low: $0.50
Ytd. Change -83.76%
50 Day Moving Average: $0.90
200 Day Moving Average: $3.92
Shares Outstanding: 2467256

Valuation

Market Cap: 169.1M
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A